Despite meeting with executives looking to avert potential litigation, the Department of Justice is planning to intervene in UnitedHealth Group's acquisition of home health company Amedisys.

Amedisys (AMED) came out with quarterly earnings of $1 per share, missing the Zacks Consensus Estimate of $1.14 per share. This compares to earnings of $0.98 per share a year ago. These figures ...

BATON ROUGE, La. (AP) — BATON ROUGE, La. (AP) — Amedisys Inc. (AMED) on Wednesday reported third-quarter earnings of $16.9 million. The Baton Rouge, Louisiana-based company said it had net ...

UnitedHealth's (NYSE:UNH) planned $3.3 billion acquisition of Amedisys (NASDAQ:AMED) is likely to close despite reports that ...

UnitedHealth Group Inc. and Amedisys Inc. representatives are slated to meet with top Justice Department antitrust enforcers next week in a last-ditch effort to persuade the agency not to ...

Amedisys (NASDAQ:AMED) rose 3.3% after UnitedHealth (NYSE:UNH) late Friday disclosed an agreement with VitalCaring Group to ...

A stock is considered to be oversold if the RSI reading falls below 30. In trading on Thursday, shares of Amedisys, Inc. (Symbol: AMED) entered into oversold territory, hitting an RSI reading of ...

Amedisys, Inc. is being acquired by UnitedHealth for $3.3 billion, pending DOJ approval, with the stock currently trading below the offer price. The DOJ is scrutinizing the merger due to concerns ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Amedisys shares have risen roughly 3% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $97.71, a rise of nearly 6% in the last 12 months.